Page last updated: 2024-09-04

docetaxel anhydrous and Cancer of Maxillary Sinus

docetaxel anhydrous has been researched along with Cancer of Maxillary Sinus in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clauditz, T; Knecht, R; Laban, S; Muenscher, A; Schafhausen, P; Tribius, S; Veldhoen, S; Zielinski, V1
Fouret, P; Handra-Luca, A; Planchard, D1
Adachi, M; Fujimoto, Y; Hagiwara, S; Lai, SY; Mitsudo, K; Shigetomi, T; Tohnai, I; Yamamoto, N1
Culliney, B; Harrison, LB; Hauerstock, D; Hu, KS; Jacobson, A; Li, Z; Manolidis, S; Mourad, WF; Persky, M; Schantz, S; Shourbaji, RA; Tran, T; Urken, M1
Kawabori, S; Taniguchi, M; Watanabe, A1

Reviews

2 review(s) available for docetaxel anhydrous and Cancer of Maxillary Sinus

ArticleYear
Management of sinonasal undifferentiated carcinoma with intracerebral invasion: Clinical experience at a single institution and review of the literature.
    Ear, nose, & throat journal, 2016, Volume: 95, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma; Chemoradiotherapy; Cisplatin; Docetaxel; Fluorouracil; Humans; Induction Chemotherapy; Magnetic Resonance Imaging; Male; Maxillary Sinus Neoplasms; Neoplasm Invasiveness; Otorhinolaryngologic Surgical Procedures; Taxoids; Tomography, X-Ray Computed

2016
Trimodality management of sinonasal undifferentiated carcinoma and review of the literature.
    American journal of clinical oncology, 2013, Volume: 36, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Maxillary Sinus Neoplasms; Middle Aged; Neoadjuvant Therapy; Preoperative Care; Retrospective Studies; Taxoids; Treatment Outcome

2013

Trials

1 trial(s) available for docetaxel anhydrous and Cancer of Maxillary Sinus

ArticleYear
Trimodality management of sinonasal undifferentiated carcinoma and review of the literature.
    American journal of clinical oncology, 2013, Volume: 36, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Maxillary Sinus Neoplasms; Middle Aged; Neoadjuvant Therapy; Preoperative Care; Retrospective Studies; Taxoids; Treatment Outcome

2013

Other Studies

3 other study(ies) available for docetaxel anhydrous and Cancer of Maxillary Sinus

ArticleYear
Docetaxel-cisplatin-radiotherapy in adenoid cystic carcinoma with high-grade transformation.
    Oral oncology, 2009, Volume: 45, Issue:11

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenoid Cystic; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Humans; Magnetic Resonance Imaging; Maxillary Sinus Neoplasms; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Radiotherapy, Conformal; Taxoids; Tomography, X-Ray Computed

2009
Chemoradiotherapy for maxillary sinus adenoid cystic carcinoma using superselective intra-arterial infusion via a superficial temporal artery.
    Head & neck, 2013, Volume: 35, Issue:3

    Topics: Adult; Antineoplastic Agents; Carcinoma, Adenoid Cystic; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Humans; Infusions, Intra-Arterial; Male; Maxillary Sinus Neoplasms; Middle Aged; Taxoids; Temporal Arteries; Treatment Outcome

2013
[A case of a 91-year-old woman with maxillary sinus carcinoma who achieved a complete response to chemoradiotherapy with intra-arterial administration of docetaxel].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:12

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Combined Modality Therapy; Docetaxel; Female; Humans; Infusions, Intra-Arterial; Maxillary Sinus Neoplasms; Remission Induction; Taxoids

2003